Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 10Parkinson Disease 4, Autosomal Dominant Lewy Body 9Squamous Cell Carcinoma of Head and Neck 8Ovarian Neoplasms 8Melanoma 8Head and Neck Neoplasms 8Lung Neoplasms 6Neoplasms 5Fallopian Tube Neoplasms 5Colorectal Neoplasms 4Carcinoma, Transitional Cell 4Stomach Neoplasms 3Neoplasm Metastasis 3Lymphoma 3Glioblastoma 3Endometrial Neoplasms 3Carcinoma, Renal Cell 3Triple Negative Breast Neoplasms 2Small Cell Lung Carcinoma 2Pancreatic Neoplasms 2Esophageal Neoplasms 2Carcinoma, Ovarian Epithelial 2Carcinoma, Hepatocellular 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Unresectable or Metastatic Solid Tumors 1Thymus Neoplasms 1Thymoma 1Spinocerebellar Degenerations 1

Interventions

pembrolizumab 5Oxaliplatin 3Nivolumab 3sintilimab 2Leucovorin 2Immune Checkpoint Inhibitors 2Fluorouracil 2Capecitabine 2Bevacizumab 2vicriviroc 1trifluridine tipiracil drug combination 1spartalizumab 1relatlimab 1regorafenib 1epacadostat 1dabrafenib 1copanlisib 1binimetinib 1atezolizumab 1Tiragolumab 1Irinotecan 1Fulvestrant 1E7046 1Cetuximab 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Spinocerebellar Degenerations × epacadostat × Clear all
NCT03182894 2018-08-28

Epacadostat in Combination With Pembrolizumab and Azacitidine in Subjects With Metastatic Colorectal Cancer

University of Pittsburgh

Phase 1/2 Withdrawn
Gastrointestinal

Spinocerebellar Degenerations, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡